ABSTRACT: DDH is a debilitating condition characterized by incomplete formation of the acetabulum leading to dislocation of the hip, suboptimal joint function and accelerated wear of the articular cartilage resulting in early onset crippling arthritis of the hip in 20-40 year olds. Current diagnostic tests in newborns using physical manipulation of the femur or ultrasound either under or over-diagnose this condition. Developing an accurate, cost effective diagnostic test is a goal of this study. To better understand the biologic pathways involved in acetabular development, DNA from severely affected individuals in a four generation family that showed inter-generational transmission of the disorder was isolated and whole exome sequenced. A novel A to C transversion at position 183721398 on human chromosome four was found to co-segregate with the affected phenotype in this family. This mutation encodes a glutamine to proline change at position 2665 in the Teneurin 3 (TENM3) gene and was judged damaging by four prediction programs. Eight week old knock-in mutant mice show delayed development of the left acetabulum and the left glenoid fossa as shown by the presence of more Alcian blue staining on the socket rims of both the hip and the shoulder. We hypothesize that mutated TENM3 will slow chondrogenesis. MMP13 has been shown to impair extracellular matrix remodeling and suppress differentiation. Bone marrow cells from the knock-in mouse were found to overexpress MMP13 with or without BMP2 stimulation. This variant may elucidate pathways responsible for normal hip development and become part of an accurate test for DDH. ß
Background
Developmental dysplasia of the hip (DDH) is a debilitating condition characterized by incomplete formation of the acetabulum leading to frequent subluxation or dislocation of the hip joint, suboptimal joint function and accelerated wear of the articular cartilage resulting in early onset crippling arthritis of the hip in young and middle aged individuals. 1 DDH affects 1 in 500-1000 newborns in the United States and Germany with well defined "pockets" of high prevalence (3-10%) in Japan and a number of Mediterranean countries. 2 The direct cost of medical care due to arthritis of the hip and its complications has been estimated at $2827 per year per patient for patients under 65. The hip osteoarthritis prevalence in the US is 51 million resulting in direct medical costs >$100 billion per year. 3 Because of its high prevalence and undesirable consequences, screening programs involving manipulation of the femur or ultrasound imaging of the hip in infants are in place in most countries. 4 Although reasonably accurate for detecting gross forms of hip dysplasia, physical manipulation techniques fail to find milder forms of dysplasia. 5 Ultrasound imaging is known to be too sensitive often resulting in overdiagnosis of DDH. Undetected hip dysplasia is the leading cause of osteoarthritis of the hip in young individuals, accounting for 40-60% of cases in the 20-40 year old age group. 5 A sensitive, specific, accurate and cost-effective test for DDH has remained a desirable yet elusive goal in orthopaedic medicine for a long time. Since DDH results in a potentially reversible delay in hip socket formation, once accurately detected, it can be treated non-invasively by immobilizing the hips of new-born infants in a Pavlik harness for about 6 weeks to allow additional time for the hip socket to develop. DDH is a complex disorder having an etiology that is both environmental and genetic. [6] [7] [8] Environmental risk factors include breech presentation, oligohydramnios, and primiparity. [9] [10] [11] Evidence for a genetic cause is well established and includes a higher concordance between monozygotic (41%) than dizygotic (2.8%) twins, and a 12-fold increase of DDH among first degree relatives of those affected by the disorder. 12, 13 DDH appears to be transmitted in an autosomal dominant fashion in several families and, perhaps because of its complex etiology, exhibits incomplete penetrance. 14, 15 The goal of this study is to determine if DDH affected individuals, in a family that shows intergenerational transmission of this disorder, have novel mutation(s) or known genetic variants that make them susceptible to the disorder. In a previous study on a large multi-generation family, we identified a variant in the chemokine receptor CX3CR1 known to affect bone metabolism. 16, 17 Since DDH is likely to be genetically heterogeneous, in this study we explore the possibility that another susceptibility inducing mutation might be present in a second smaller affected family. Our findings indicate that a novel mutation in Teneurin 3, that maps to chromosome 4q35 and slows development of the murine acetabulum and glenoid fossa might contribute to this disorder.
METHODS

Clinical Diagnostic Criteria
Before the initiation of this study, approval was obtained from the Institutional Review Board of Thomas Jefferson University and informed consent was obtained from each participant. All animals in this study were treated under guidelines established by The Institutional Animal Care and Use Committee (IACUC) at Thomas Jefferson University.We have recruited a family from Philadelphia that shows transmission of DDH through three generations and isolated DNA from 15 family members (Fig. 1) . Individual family members were diagnosed using clinical exams and supine anterior posterior radiographs of the pelvis. Imaging of the hips was evaluated by three orthopaedic surgeons, with clinical opinions of two additional surgeons elicited in any cases of disagreement. Shenton's line (disrupted ¼ affected), Center Edge Angle (<20 degrees ¼ affected), Tonnis Angle (>10 degrees ¼ affected), Extrusion Distance (>10mm ¼ affected) and Femoral Neck angle were measured in each radiograph and compared to control values derived from 11 independent studies. In general, those individual family members with one or two signs of DDH were deemed questionable, those with three or more signs affected.
Whole Exome Sequencing
Three severely affected family members with three or more signs of the disorder were selected for whole exome sequencing and for analysis of shared exonic variants. Control reference sequence was derived from the 1000 Genome project (http://www.1000genomes.org) and from the GRCh37 assembly of NCBI. Exome capture on each individual was performed using SureSelect Human All Exome kit v.1 (Agilent technologies) and sequencing was performed using a Genome Analyzer IIx (Illumina Inc). Sequence reads were mapped to the reference genome using the Burrows Wheller Aligner Tool (BWA). An average of 97.25 million reads were available for each individual of which 92.5% aligned to the targeted region. An average of 91.6% targeted regions were covered at a read depth of at least 20x. The Ts/Tv ratio was 2.36 for all on target reads and 2.41 for exonic reads.
For each sample, raw data in fastq format was aligned using BWA (version 0.5.9, settings: "aln Ào 1 Àe 10 Ài 5 Àl 32 Àk 2 Àt 17") to the human genome (hg19, 37.p10). Aligned reads were then subjected to local realignment, duplicate marking, and score recalibration via Picard tools (version 1.58, settings available upon request). These final aligned read were used for variant calling using GATK (version 1. The list of variants from all three affected individuals was filtered and the following variants were retained: (1) variants shared by all three affected individuals with a quality score greater than 20. Quality scores measure the probability that a base is called incorrectly. The quality score of a given base, Q, is defined by the equation Q ¼ À10log 10 (e) where e is the estimated probability of the base call being wrong. Thus, a higher quality score indicates a smaller probability of error.
For example a quality score of 20 represents an error rate of 1 in 100, with a corresponding call accuracy of 99%. (2) Variant that had sequencing depth scores greater than 19 (3) Variants that passed the quality control imposed by GeneSifter (3) new mutations (those not found in dbSNP135), non-synonymous SNPs and splice sites causing variants within subset.
Non-synonymous or novel variants shared by all three affected individuals were evaluated for functional effects on the protein they encoded using Provean, Mutation Taster and PMUT. [18] [19] [20] These prediction programs use structural features of the protein as well as information on evolutionary conservation to predict whether a mutation affects protein function. Variants were screened for biological significance by determining Genomic Evolutionary Rate Profiling (GERP) scores. 21 GERP identifies evolutionarily constrained elements in multiple alignments by quantifying substitution deficits. These deficits represent substitutions that would have occurred if the element were neutral DNA, but did not occur because the element has been under functional evolutionary constraint.
Mutation Filter Criteria
Filtering whole exome variants for relevance to bone using Ingenuity software: Starting with 1,149,319 variants spanning 20,018 genes, variants were: Excluded that are (1) observed with an allele frequency greater than or equal to 0.1% of the genomes in the 1000 genomes project or (2) greater than or equal to 0.1% of the public Complete Genomics genomes or (3) greater than or equal to 0.1% of the National Heart Lung and Blood Institute Exome Sequencing Project (NHLBI ESP) exomes. Retained data were those (1) experimentally observed to be associated with a phenotype: Pathogenic, possibly pathogenic, unknown significance or (2) established gain of function in the literature or gene fusions or inferred activating mutations by Ingenuity or (3) predicted gain of function by SIFT, a program that Sorts Intolerant From Tolerant variants 22 or (4) resided in a microRNA binding site or (5) were non-synonymous and not predicted to be innocuous by SIFT or (6) disrupt splice site or (7) were deleterious to a microRNA. Retained data also included those data that are associated with gain of function or were compound heterozygous or homozygous or heterozygous or haploinsufficient or hemizygous and have call quality greater than 20 and occur in at least three of the case samples at the variant level. Finally data passing the previously described screens were filtered for those variants that are known or predicted to directly affect bone formation using the Ingenuity Variant analysis program.
Versions of software used in this analysis were: Ingenuity Variant Analysis version 1. Validation of the sequencing results in the three severely affected members and in other family members and in-laws (individuals married-into the family) was performed using Sanger DNA sequencing.
Computer modeling of the scFv structure-Protein fragments spanning the mutated p.2665 site of the wild type and mutant variants of teneurin-3 were submitted for homology modeling to the Swiss-Model server (http://swissmodel. expasy.org/). Subsequently, the quaternary structures of the analyzed regions were analyzed with the use of the Sybyl software (Tripos Inc.). Molecular surfaces of the analyzed fragments were generated using the MOLCAD module of the Sybyl program. The same module was used to calculate lipophilic potential (LP) and electrostatic potential (EP, physical unit; kcal/mol e) of the analyzed fragments. (Fig. S2) . The targeting vector further contains 0.8 kb and 1.5 kb homologous arms flanking this central region. Because mutant mouse exon 31 is present in reverse orientation, the mutant Q2665P form cannot be expressed until after Cre-mediated recombination has occurred. Thus, when this construct is inserted into the endogenous Tenm3 locus, exposure to Cre-mediated recombination will lead to consecutive inversion of the mutant Exon 31 and deletion of the wt exon 31, resulting in precise replacement of wt exon 31 by mutant exon 31.
Strains of Mice: B6.Cg-Tg(Prrx1-cre)1Cjt/J; Stock Number: 005584 (Jackson Labs) B6C3F1/J Stock No: 100010 Jackson labs The purified double-strand repair DNA construct, described above, was microinjected (at 2 ng/ml) into pronuclei of d0.5 B6C3F2 embryos from B6C3F1xB6C3F1 matings, together with ZFNs Tenm3-3/4 (recognizes ACCTCATCTAAGAC CCGTTTnnTTTCCTGGCTGGCTGAG) and Tenm3-5/6 (recognizes TGCGCTACTTTCTATCACTTAnATAGATAGGACCT GTGCAGTC) (at 20 ng/ml). Injected embryos were implanted into the oviducts of d 0.5 pseudopregnant female Swiss Webster mice. Tails from the resulting pups were clipped 2 weeks after birth for genotype analysis. Presence of the correct knock-in event was confirmed by PCR amplification. PCR assays were designed for both 5 0 and 3 0 ends of the targeted insertion, in each case using one primer located within the endogenous Tenm3 gene but outside the targeting construct, to avoid detecting integration of the construct at random sites. The 5 0 PCR assay employed primers F1 þ R2, which detects no band for the unmodified wt allele, but a specific 3.0 kb band for the conditional modified allele. The 3 0 PCR assay employed primers F4 þ R4, which detects no band for the unmodified wt allele, but a specific 1.9 kb band for the conditional modified allele.
Typing primers:
A single founder (SP55) was identified that was positive for both 5 0 and 3 0 PCR assays. DNA sequencing confirmed that the construct was correctly inserted.
Establishment of conditional Q2665P Tenm3 mouse line: Founder SP55 was backcrossed to a mouse carrying the Prrx1-cre transgene, and F1s typed for both the mutant Tenm3 allele and the Cre transgene, using foloowing primer sequences and amplification conditions: . Tenm3-Cre genotyped cells were cultured in chondrogenic media (time 0) with and without BMP2 (200 mg/ml). BMP2 was added to chondrogenic medium from day 7 to day 12 then removed and cells were allowed to grow until day 21. At days 7,14 and 21 total RNA was extracted quantitated, converted to cDNA and quantitated with real time PCR.
RNA was quantitated by Nano drop (Thermo Scientific Nano drop one) and was converted to cDNA using TaKaRa clontech RNA to cDNA Eco dry Premix (cat# 639543) Primers for mmp13: RNA analysis was carried out using Image Pro ÀPlus 6.0 software.
RESULTS
Description of the affected family: This four generation, Caucasian, 15 member family shows transmission of DDH in a manner consistent with an autosomal dominant mode of inheritance with incomplete penetrance.
X linked inheritance for the family was ruled out by the male to male transmission of the affected allele from obligate heterozygote 6 to affected individual 9 ( Fig. 1 ). Three family members had three or more signs of DDH and were considered to be unequivocally affected (see Methods). Four individuals had one or two signs of DDH and had questionable diagnoses. Whole exome sequencing of individuals 1, 9 and 11: Of the total of 1,149,319 DNA variants found in this family 123,952 were shared by the three severely affected individuals 1, 9 and 11. 5498 of these were judged to have a moderate or high biological impact. 4255 of these were further screened to eliminate low quality variants leaving 4204 non-X linked variants consisting of 4159 known variants and 45 novel variants. (See Fig. S1 4255 variants passing filters.xls) Further screening using Ingenuity software (see Methods) and manual inspection revealed that 20 of those variants were found relevant to chondrogenesis or osteogenesis. After Sanger sequencing of the DNA of all available family members, only one variant was found to: (1) be excluded from all unaffected married in individuals and unrelated controls and (2) co-segregate in all severely affected family members, all family members with milder signs of DDH and in all obligate heterozygotes and (3) be in the coding sequence of a gene expressed tissue specifically in the femoral cartilage of 1 day old mice 25 (see flow chart Fig. 2 ). Description of the mutation: This novel mutation, an A to C change at position 183721398 on chromosome four codes for a glutamine to proline change at amino acid 2665 in the TENM3 gene. The Tenm3 gene encodes a transmembrane protein thought to function as a cell signal transducer. It is expressed in the developing murine nervous system and in the femoral cartilage of 1 day old mice. Figure 3 demonstrates the segregation of the mutation in the affected family. The mutated C allele is coinherited by severely affected individuals 1, 9 and 11 in the family as well as by obligate heterozygotes 6 and 2. Less affected individuals 5, 8 and 13 also appear to have inherited the mutant allele. The affected allele appears to have originated in individual 20 whose DNA was not available for this study. In addition, the normal A allele was found in two unrelated control adults with no family history of DDH and no radiographic signs of DDH (results not shown).
Biologic Significance To determine the potential biological significance of this mutation programs that predict the effects of DNA changes on the function of the encoded protein were run. Table 1 shows the results of three programs designed to predict the effect of a given mutation on protein function. All three programs predict harmful effects of this amino acid substitution on Tenm3 function. Additonally the tenm3 amino acid residues 2648-2694 of the Tenm3 protein were modeled to depict lipophilic and electrostatic potentials in the wild type and mutant fragment of the Tenm3 protein. The "wire-like" model Figure 4A depicts the backbones of the wild type (WT) (green) and mutant (MT) (red) variants. From the different views of the presented models it is apparent that the energy-minimized structure of the P2665 variant differs from that observed for the Q2665 WT for both electrostatic potential (EP) and lipophilic potential (LP) or hydrophobicity. The following ranges were obtained: The above values, given for the whole analyzed fragments, provide some information about differences between critical physicochemical characteristics of WT and MT.
Effect of Tenm3 Q2665P mutation on skeletal development in knockin mice.
To determine the effect of this potentially harmful mutation on skeletal development in an animal model, the Prrx1 enhancer, active in the developing limb bud mesenchyme, was used to drive the expression of the mutant Tenm 3 allele. Prrx-1 Cre mice that express Cre recombinase under control of a Prrx enhancer were crossed with Tenm3 mutants. Figures 5A and D show Alizaran red, Alcian blue staining of the acetabula and glenoid fossae of mutant and wild type female littermates. Genotyping and crossing has revealed all offspring to be heterozygous for the mutated Tenm3 allele.
Figure 5B reveals more cartilage in the acetabular rim of the left hip of the knock-in mouse at 8 weeks.
Similarly the left glenoid fossa of 8-week-old Tenm3 mutated mice had more remaining cartilage than found in controls ( Fig. 5C and D) . To test our hypothesis that mutated TENM3 will slow chondrogenesis, we examined the effect of this mutation on the expression of MMP13, COLX and VEGF in femur derived bone marrow cells (Fig. 6) . From d7 to d21 MMP13 expression increases occurred in both wt and mutated mesenchymal stem cells. Our data shows 20% further increased levels of MMP expression at day 7 with (p ¼ 0.0369) and without (p ¼ 0.0682) bmp2 stimulation in mutated mscs compared to controls. This increase continued until day 14 (p ¼ 0.0302) in mutated MSCs exposed to BMP2. No effect of Bmp2 stimulation was found on the COLX and VEGF genes in mutated and control samples (not shown). 
DISCUSSION
Using high throughput whole exome sequencing we have found a novel mutation in the Tenm3 trans-membrane protein that is co-inherited by all severely affected individuals and all obligate heterozygotes and absent from the DNA of all married-in family members and unrelated controls. Consistent with previous families showing intergenerational inheritance of DDH, this family shows an autosomal dominant pattern of inheritance with instances of non-penetrance. It can be inferred that the mutated allele originated in individual 20 whose DNA was not available. Obligate heterozygote, individual 2, is non-penetrant for DDH. It is not unusual to find examples of non-penetrance in a complex disorder like DDH as environmental factors are known to affect the phenotype. Indeed, the DDH affected South African family studied by Roby and his colleagues and families investigated by other researchers have shown non-penetrance. 14, 15, 26, 27 Recently it has been reported that a South African family suffering from Beukes developmental dysplasia of the hip is caused by a missense mutation in the ubiquitin-fold modifier 1-specific peptidase 2 ((UFSP2) gene which resides at 4q35.1, a location near the TENM3 gene. 28 There are a number of phenotypic features that differentiate the family reported here from the South African one. Radiographs of our affected family members do not indicate signs of Beukes type hip dysplasia. Pronounced flattening of the femoral head (coxa plana) and broadening and shortening of the femoral neck, pathognomonic signs of Beukes, are absent. Moreover, no harmful UFSP2 variants shared by the three most affected members in our family in our in depth whole exome sequencing database were found. The development of the hip socket involves the timed, tissue specific interaction of many genes and it is likely that DDH will be genetically heterogeneous. The novel mutation found in the protein coding domain of the Teneurin 3 (Tenm3) causes an A to C nucleotide alteration at position 183721398 on chromosome 4 encoding a glutamine to proline change at position 2665 in the Teneurin 3 protein. Teneurin3 is a member of the teneurin family, a class of multifunction transmembrane proteins. One of these functions is thought to be signal transduction. Although originally found to be strongly expressed in the developing nervous system, teneurins mRNA can be found in the developing limb bud. Recently, it has been discovered that Tenm3 is expressed in prechondrogenic mesenchymal cells and may directly be involved in the early stages of chondrogenic differentiation. [29] [30] [31] [32] Murakami and his colleagues have found Tenm3 to be most strongly expressed in the perichondrium and proliferating chondrocytes in the femoral cartilage of 1 day old mice. 25 Specifically, expression was strongest in the fibrous layer which is thought to be the source of chondrogenic cells. Importantly this expression appeared to be stage specific as it was expressed at a lower level in mature articular chondroctyes and was absent in hypertrophic chondrocytes. 25, 27 The C terminal extracellular fragment of 40 acid residues of tenm3 in the extracellular domain is cleaved. This cleaved segment is flanked by a prohormone cleavage motif on the amino terminal region of the sequence and an amidation motif on the carboxy terminal region. 30 The cleaved peptide, teneurin c terminal associated peptide (TCAP), has been shown to be biologically active in vitro and in vivo. 31 Indeed, TCAP 3 protein bears the hallmark of a cleavable bioactive peptide having a basic residue next to the mature peptide and an R/K-Xn-R/K prohormone convertase cleavage motif.
32
TCAP3 has a strong amino acid homology with the middle section of the human calcitonin preprohormone in the immediate vicinity of and including the glutamine to proline mutation at position 2665 in tenm3. 22 The mutated glutamine is 10 amino acids downstream of the TCAP cleavage site and might affect its ability to separate from the tenm3 molecule (Fig. 7) .
Various programs have been used to predict the effect of the glutamine to proline coding substitution (Table 1 ). All three programs predict harmful effects on protein function. Additonally the tenm3 amino acid residues 2648-2694 of the Tenm3 protein were modeled to depict lipophilic and electrostatic properties in the wild type and mutant fragment of the Tenm3 protein revealing significant differences between wild type and mutant protein ( Fig. 4A and B) . Consistent with these findings is the fact that this glutamine to proline mutation is highly conserved in many species from primates through the frog, Xenopus tropicalis with a GERP (Genomic Evolutionary Rate Profiling) score of 3.69. Scores greater than zero reflect evolutionary constraint. 21 To test our hypothesis that this DNA alteration slows chondrogenesis we have created a knockin mouse with tissue and stage specific expression of the mutant allele driven by the Prrx1 enhancer which is active in the developing limb bud mesenchyme. Six and eight week old mutant mice show delayed development of the left acetabulum and the left glenoid fossa as shown by the presence of more Alcian blue staining on the socket rims of both the hip and the shoulder. No detectable difference was found on the right side. This unilateral phenotype mirrors that found in DDH where many individuals and families show affection on one side. 4, 5 The cause of this is not known but may be related to environmental factors.
Recently it has been demonstrated that Teneurin 4 (Tenm4) is also expressed in mesenchymal tissues including cartilage. It also has been found to be a novel regulator of chondrogenesis suppressing chondrogenic differentiation. 33 Thus the Tenm3 and Tenm4 may be acting in opposite ways to regulate the temporo-spatial expression of cartilage. We have found that femur derived mutated bone marrow stem cells when stimulated with BMP2 show increased expression of MMP 13 compared to normal controls. In 2014 Ning, Sun and colleagues created an animal model of DDH by modifying the swaddling position of the hips in newborn Wistar rats. 28 They showed that higher levels of MMP13 and of beta catenin mRNA and protein were present in chondrocytes and that hip joints in the swaddled animals underwent articular cartilage degeneration. Our results showing higher MMP13 in TENM3 mutated mice are consistent with this observation and support TENM3's role in increasing susceptibility to DDH.
Limitations of this study include the fact that there may also be DNA variants that reside in the intergenic regions of the human genome that were not covered by our analysis. Additonally, candidate gene selection is based on current knowledge of function and may have missed potentially important causative variants.
In summary, a novel mutation on chromosome 4q35 has been uncovered in a multi-generation affected family. This mutation, which might play a causative or susceptibility inducing role for DDH, resides near the amino terminal, cleavable end of TCAP domain of Teneurin 3, a potential signaling transmembrane protein known to be expressed contemporaneously with acetabular formation in the 1 day old mouse. Within the TCAP domain is a motif bearing strong homology to calcitonin-a hormone associated with endochondral bone formation in early life.
Since affected individuals in this family exhibit haplo-insuffiency of the Tenm3 gene, it might be expected that this mutation would attenuate not obliterate protein function. Gene dosage, timing of expression, tissue sensitivity and the unique morphology of the developing acetabulum all create the microenvironment in which this mutation acts. This finding suggests the new hypothesis that this mutation in the TCAP region of Tenm3 delays the maturation of mesenchymal cells destined to become chondrocytes. This mutation and others that remain to be found in other families and sporadic individuals may begin to elucidate the pathways responsible for normal hip development.
